Skip to main content
logo
Anixa Biosciences, Inc. (ANIX)
NASDAQ: ANIX · Real-Time Price · USD
3.050
+0.010 (0.33%)
At close: Apr 24, 2026, 4:00 PM EDT
3.190
+0.140 (4.59%)
After-hours: Apr 24, 2026, 7:54 PM EDT

Anixa Biosciences Ratios and Metrics

Millions USD. Fiscal year is Nov - Oct.
Fiscal Year
CurrentFY 2025FY 2024FY 2024FY 2023FY 2022
Period Ending
Apr '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21
Market Cap
10213611398173143
Market Cap Growth
18.08%20.99%14.50%-43.15%20.77%186.96%
Enterprise Value
88.25120.1391.8673.73142.76107.17
Last Close Price
3.054.133.503.165.604.77
PE Ratio
--12.48-8.97-9.87-12.44-10.60
PS Ratio
---468.66-279.97
PB Ratio
6.778.995.644.045.964.04
P/TBV Ratio
6.618.995.584.025.863.85
P/FCF Ratio
--19.01-15.36-15.85-26.67-29.03
P/OCF Ratio
--19.01-15.36-15.85-26.67-29.03
EV/Sales Ratio
---351.10-209.31
EV/EBITDA Ratio
--10.30-6.66-6.72-10.32-8.20
EV/EBIT Ratio
--10.27-6.64-6.70-10.29-8.16
EV/FCF Ratio
--16.75-12.52-11.87-21.99-21.70
Debt / Equity Ratio
0.010.010.010.010.010.01
Debt / EBITDA Ratio
-0.02-0.02-0.02-0.02-0.02-0.02
Debt / FCF Ratio
-0.03-0.03-0.03-0.03-0.03-0.05
Net Debt / Equity Ratio
-0.93-0.99-0.98-0.97-1.01-1.00
Net Debt / EBITDA Ratio
1.221.281.432.162.132.71
Net Debt / FCF Ratio
1.872.092.693.814.547.18
Asset Turnover
-000.0100.02
Quick Ratio
11.497.718.0411.8914.6028.13
Current Ratio
12.188.088.5412.5014.8328.35
Return on Equity (ROE)
-77.47%-67.17%-60.10%-38.51%-43.74%-61.02%
Return on Assets (ROA)
-73.42%-62.12%-58.71%-39.37%-41.62%-57.48%
Return on Invested Capital (ROIC)
1943.36%1283.00%2510.16%1408.06%1410.78%1826.36%
Return on Capital Employed (ROCE)
-81.79%-70.48%-64.96%-42.46%-43.80%-60.74%
Earnings Yield
-10.08%-8.01%-11.14%-10.13%-8.04%-9.43%
FCF Yield
-6.73%-5.26%-6.51%-6.31%-3.75%-3.44%
Buyback Yield / Dilution
-1.96%-3.50%-2.96%-2.00%-6.28%-28.57%
Total Shareholder Return
-1.96%-3.50%-2.96%-2.00%-6.28%-28.57%
Updated Jan 31, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q